RDH5 Antibodies

Santa Cruz Biotechnology features a diverse variety of RDH5 monoclonal antibodies for research in understanding RDH5 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).RDH5, or Retinol Dehydrogenase 5, is a crucial enzyme involved in the metabolism of retinoids, which are vital for vision and cellular function. RDH5 plays a significant role in the visual cycle, converting all-trans-retinol to 11-cis-retinol, a key step in the regeneration of visual pigments in the retina. Understanding RDH5 function is essential for elucidating mechanisms underlying retinal diseases and potential therapeutic targets. Research has shown that mutations in RDH5 can lead to various visual impairments, highlighting its importance in maintaining healthy vision. Recent studies have also suggested potential roles for RDH5 beyond the visual cycle, opening new avenues for investigation. Characterization of RDH5 continues to reveal its significance in both normal physiology and disease states. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of retinal biology and vision-related disorders.